Current status of sentinel lymph node biopsy in adenocarcinoma of the distal esophagus, gastric cardia, and proximal stomach.
Gretschel S, Schlag PM.
Recent Results Cancer Res. 2010;182:107-14. doi: 10.1007/978-3-540-70579-6_9.
PMID:20676875
Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.
Odze RD.
Am J Gastroenterol. 2005 Aug;100(8):1853-67. doi: 10.1111/j.1572-0241.2005.50096.x.
PMID:16144130
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr; North Central Cancer Treatment Group.
Ann Oncol. 2006 Jan;17(1):29-34. doi: 10.1093/annonc/mdj063. Epub 2005 Nov 22.
PMID:16303863
Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, Ancona E, Peracchia A.